Revenue (TTM) Chart

View Revenue (TTM) for CDNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 458.09M
March 31, 2026 412.82M
December 31, 2025 379.80M
September 30, 2025 358.00M
June 30, 2025 340.83M
March 31, 2025 346.42M
December 31, 2024 333.78M
September 30, 2024 312.78M
June 30, 2024 297.08M
March 31, 2024 275.11M
December 31, 2023 280.32M
September 30, 2023 297.14M
June 30, 2023 309.31M
March 31, 2023 319.64M
December 31, 2022 321.79M
September 30, 2022 318.63M
June 30, 2022 314.86M
March 31, 2022 308.41M
December 31, 2021 296.40M
September 30, 2021 275.82M
June 30, 2021 253.60M
March 31, 2021 221.21M
December 31, 2020 192.19M
September 30, 2020 169.37M
June 30, 2020 149.81M
Date Value
March 31, 2020 139.47M
December 31, 2019 127.07M
September 30, 2019 114.76M
June 30, 2019 102.13M
March 31, 2019 88.50M
December 31, 2018 76.57M
September 30, 2018 65.56M
June 30, 2018 56.57M
March 31, 2018 50.79M
December 31, 2017 48.32M
September 30, 2017 46.68M
June 30, 2017 46.96M
March 31, 2017 45.65M
December 31, 2016 40.63M
September 30, 2016 36.42M
June 30, 2016 31.10M
March 31, 2016 27.49M
December 31, 2015 28.14M
September 30, 2015 28.95M
June 30, 2015 28.45M
March 31, 2015 28.10M
December 31, 2014 26.81M
September 30, 2014 24.81M
June 30, 2014 23.14M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Natera, Inc. 2.707B
Caris Life Sciences, Inc. 989.60M
Myriad Genetics, Inc. 806.60M
BioRestorative Therapies, Inc. 0.3579M
Exagen, Inc. 71.12M